Instrumento Inactivo

Otros idiomas Qlife Holding AB (publ) Nasdaq Stockholm

Acciones

SE0013486552

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Qlife Holding AB enters into an addendum with the holders of the company's convertible debentures and all outstanding convertible debentures are converted into shares	08/05
Qlife Places Danish Operational Company in Reconstruction Mode	05/04
Qlife informs that it has put its Danish operational company into reconstruction mode as a temporary measure	04/04
Sweden's Qlife to Launch Biomarker Testing Platform in South Korea Via Potential Partnership	25/03
Qlife signs letter of intent with South Korean company Precision Biosensor as part of B2B strategy to enter major markets with Egoo Health, through hospital@home partnerships	25/03
Qlife Signs Letter of Intent with Precision Biosensor	25/03
Qlife is emphasizing that the call today for an extraordinary general meeting (EGM) is a necessity according to Swedish law, but that the company otherwise is following its plans.	21/03
Qlife Secures Core Patent for Egoo System in EU, UK Markets	23/02
Qlife Announces its Core Patent for Egoo System Grants in EU and Other Countries in European Market, as Well as in United Kingdom	23/02
Qlife Holding AB Announces Update on Collaboration with Hipro Biotechnology	16/02
Qlife publishes prospectus due to upcoming rights issue of units	09/02
Qlife Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	09/02
Qlife Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	09/02
Qlife Holding AB Postpones the Publication of the Year-End Report for the Financial Year 2023 Until 8 February 2024	04/02
Bulletin from the extraordinary general meeting in Qlife Holding AB on 16 January 2024	16/01
Notice of extraordinary general meeting in Qlife Holding AB	12/12
Qlife carries out a rights issue of units of approximately SEK 49.5 million	12/12
Qlife collaboration agreement with Hipro biotechnology - potential value of 500 MSEK	07/12
Qlife Enters Collaboration Agreement with Hipro Biotechnology	07/12
Qlife, Hipro Biotechnology Ink Collaboration Deal for Egoo Health; Shares Soar	04/12

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Qlife Holding AB (publ) Nasdaq Stockholm

Acciones

SE0013486552

Otros idiomas

Filtros